Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617494 · ClinicalTrials.gov registry record
Endogenous Pain Inhibition Deficiency in Chronic TMD Pain
A clinical trial of Chronic Temporomandibular Disorders (TMD), sponsored by University of Minnesota.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06617494: Recruiting study of Chronic Temporomandibular Disorders (TMD), sponsored by University of Minnesota.
NCT06617494 is a study of Chronic Temporomandibular Disorders (TMD) that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06617494, a study of Chronic Temporomandibular Disorders (TMD), is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Temporomandibular disorders (TMDs) involve a range of conditions with varied causes, affecting a large portion of the U.S. population and posing challenges for diagnosis and management, especially in chronic cases. Despite advances in understanding TMD pathophysiology, the role of central sensitization, particularly deficient endogenous pain inhibition, remains unclear. The conditioned pain modulation (CPM) test, used to assess pain inhibition in chronic TMD pain, has produced inconsistent results due to varying testing parameters. The proposed cross-sectional study will investigate the efficiency of endogenous pain inhibition in individuals with chronic TMD pain compared to controls by applying noxious and non-noxious stimuli to facial and non-facial sites. The findings aim to clarify the impact of weaker pain inhibition over the face, how the conditioning stimulus' painfulness affects inhibition and the relationship between pain inhibition and fluctuations in TMD pain intensity.
Primary Outcome
The CPM effect is manifested as a reduction of pain intensity evoked by a test stimulus (Ts) presented concurrently or right after a painful conditioning stimulus (Cs) applied to a distant body site.
Conditions Studied
Interventions
- OTHER Pain modulation testing
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-12-15 |
What NCT06617494 shows while recruiting
NCT06617494 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Chronic Temporomandibular Disorders (TMD) appearing as the primary indexed condition, and to 1 intervention - of which Pain modulation testing is the first listed.
NCT06617494 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06617494 about?
NCT06617494 is a clinical study titled "Endogenous Pain Inhibition Deficiency in Chronic TMD Pain". Temporomandibular disorders (TMDs) involve a range of conditions with varied causes, affecting a large portion of the U.S. population and posing challenges for diagnosis and management, especially in chronic cases. Despite advances in understanding TMD pathophysiology, the role of central sensitizat...
What is the current status of trial NCT06617494?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-09-16. Estimated completion is 2026-12-15.
What conditions does trial NCT06617494 study?
This clinical trial studies the following conditions: Chronic Temporomandibular Disorders (TMD).
What interventions are being tested in trial NCT06617494?
The interventions under investigation include: Pain modulation testing (OTHER).
Who is sponsoring clinical trial NCT06617494?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617494 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI